Cambria Cannabis ETF (TOKE)
| Assets | $9.78M |
| Expense Ratio | 0.42% |
| PE Ratio | 14.74 |
| Shares Out | 1.65M |
| Dividend (ttm) | $0.23 |
| Dividend Yield | 3.87% |
| Ex-Dividend Date | Mar 21, 2024 |
| Payout Ratio | 58.17% |
| 1-Year Return | -4.55% |
| Volume | 5,094 |
| Open | 6.04 |
| Previous Close | 5.96 |
| Day's Range | 5.94 - 6.05 |
| 52-Week Low | 5.11 |
| 52-Week High | 6.89 |
| Beta | n/a |
| Holdings | 30 |
| Inception Date | Jul 25, 2019 |
About TOKE
Fund Home PageThe Cambria Cannabis ETF (TOKE) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively-managed portfolio of globally-listed companies related to cannabis and hemp. TOKE was launched on Jul 25, 2019 and is issued by Cambria.
Top 10 Holdings
83.35% of assets| Name | Symbol | Weight |
|---|---|---|
| First American Treasury Obligs X | FXFXX | 26.17% |
| DEPOSITS WITH BROKER FOR SHORT POSITIONS | n/a | 16.44% |
| Cronos Group Inc | CRON.TO | 5.47% |
| Philip Morris International Inc. | PM | 5.25% |
| Imperial Brands PLC | IMB.L | 5.21% |
| GLASS HOUSE BRANDS INC SWAP | n/a | 5.07% |
| Altria Group, Inc. | MO | 5.04% |
| Turning Point Brands, Inc. | TPB | 5.02% |
| Jazz Pharmaceuticals plc | JAZZ | 4.89% |
| TRULIEVE CANNABIS CORP SWAP | n/a | 4.80% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 21, 2024 | $0.06273 | Apr 1, 2024 |
| Dec 14, 2023 | $0.05435 | Dec 26, 2023 |
| Sep 21, 2023 | $0.06063 | Oct 2, 2023 |
| Jun 22, 2023 | $0.05284 | Jul 3, 2023 |
| Mar 23, 2023 | $0.07675 | Apr 3, 2023 |
| Dec 22, 2022 | $0.05393 | Jan 3, 2023 |
News
ETF Themes That Dominated in Q1 2023
As the first quarter comes to a close, clearly, there have been some thematic winners in terms of flows and investment performance. Artificial Intelligence AI-themed ETFs remain among the top recipien...
Scotts Miracle-Gro Down 10% On Profit Warning
The stock is a holding in 119 ETFs, with cannabis funds offering the most exposure.
5 developments that cannabis investors did not expect in 2021
2021 has been an interesting year for cannabis investors with lots of positive and negative news. According to New Cannabis Ventures, following were the five developments that cannabis investors hadn'...
Marijuana ETFs Blaze Higher
Cannabis-related ETFs are moving higher on news of a Republican-backed proposal for legalization.
Pot plays and the presidency: What to expect from cannabis ETFs under Biden
Tim Seymour, chief investment officer of Seymour Asset Management and one of the brains behind the CNBS ETF, talks pot's prospects with CNBC's Bob Pisani.
Marijuana ETFs Get Second Wind
Looming U.S. federal decriminalization of cannabis breathes life into faltering sector.
Best Marijuana ETFs for Q4 2020
The best marijuana ETFs for Q4 2020 are YOLO, TOKE, and CNBS.
Here's how SPACs are changing the cannabis industry
Former Senate Majority Leader Tom Daschle and Kyler Detwiler, Clever Leaves CEO, join "Squawk Alley" to discuss cannabis regulation in the U.S. and pot stocks going public through SPACs.
3 Cannabis ETFs For 4/20
After a rough year in 2019 (to put it mildly), cannabis stocks and the related exchange-traded funds are incurring significant punishment again this year.
Cryptocurrency, cannabis and eco-conscious investing: What's ahead in 2020
Tom Lydon, CEO of ETF Trends, and Nick Colas, co-founder of DataTrek Research, talk 2020 prospects for bitcoin, cannabis and ESG with CNBC's Bob Pisani.
5 Worst ETFs Of 2019
It's been a great year for stocks. For gold, too. And plenty of corners of the bond market as well.